Pharma giant Merck is buying U.S. biotech firm Terns Pharmaceuticals for $6.7 billion, the company said Wednesday. This is the third multibillion-dollar acquisition for Merck over the past year as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results